Buy CJC No DAC + Ipamorelin Spray – Research-Grade Dual Pathway Growth Hormone Secretagogue Blend

Buy CJC No DAC + Ipamorelin Spray and obtain a convenient research-grade combination of two complementary growth hormone secretagogues supplied for laboratory and experimental use. This blend pairs CJC-1295 without DAC (also known as Mod GRF 1-29) with Ipamorelin, enabling simultaneous activation of the GHRH receptor and the ghrelin/GHS-R1a receptor pathways. The nasal spray format offers a practical delivery method for research protocols investigating synergistic, pulsatile growth hormone release. Qualified research groups select verified material for its purity and documentation.

What Is CJC No DAC + Ipamorelin?

CJC No DAC (Modified GRF 1-29) is a tetrasubstituted analog of the first 29 amino acids of growth hormone-releasing hormone. The four amino acid substitutions improve resistance to enzymatic degradation while preserving a short half-life that supports discrete, pulsatile signaling. Ipamorelin is a selective pentapeptide agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a). When combined, the two peptides activate complementary intracellular pathways in pituitary somatotrophs, producing synergistic growth hormone release greater than either compound alone in experimental models.

All research-grade CJC No DAC + Ipamorelin Spray is supplied strictly for laboratory investigation and is not intended for human or veterinary use. It is provided with analytical documentation confirming identity and purity of both components.

Key Product Specifications

• Compounds: CJC-1295 No DAC (Mod GRF 1-29) + Ipamorelin
• Form: Nasal spray solution for research use
• Purity: Typically ≥98–99% for each peptide (HPLC verified, batch-dependent)
• Documentation: Certificate of Analysis (COA) included with authentic supply
• Intended use: Laboratory and research use only
• Storage: Follow supplier guidelines (commonly refrigerated)

Researchers who order CJC No DAC Ipamorelin Spray research receive analytically characterized material suitable for in-vitro or preclinical experimental designs involving dual GHRH/GHS-R1a pathway studies.

Research Context

The combination of a short-acting GHRH analog with a selective ghrelin receptor agonist is widely used in laboratory settings to study synergistic stimulation of the growth hormone axis. CJC No DAC amplifies pulse amplitude via the GHRH receptor (cAMP/PKA pathway), while Ipamorelin increases pulse frequency via GHS-R1a (Ca²⁺/PLC pathway). The nasal spray format provides a non-injectable option for certain experimental protocols examining mucosal absorption or dual-pathway receptor pharmacology.

Because both compounds are supplied as research chemicals, all material is labeled for laboratory use only and carries appropriate professional-use disclaimers. Neither peptide in this combination has approved clinical indications in this form.

Why Laboratories Choose Verified Material

When research teams purchase CJC No DAC + Ipamorelin Spray, they prioritise analytical purity of both components, identity confirmation, and full batch documentation. High-quality suppliers provide independent COAs verifying peptide content and purity, supporting reproducible experimental outcomes.

Current professional pricing for COA-backed units positions the product within the specialized research peptide market. Volume options are available for groups establishing ongoing CJC Ipamorelin professional research supply.

Product Advantages for Research Use

• Convenient nasal spray delivery format
• Dual pathway activation (GHRH + GHS-R1a) for synergistic studies
• Short-acting No DAC profile supporting pulsatile research models
• High-purity, third-party tested material (where supplied)
• Full batch traceability via Certificate of Analysis
• Consistent quality for structured laboratory protocols

Whether you require a single unit for preliminary assays or prefer CJC No DAC Ipamorelin nasal spray wholesale arrangements for larger studies, source exclusively from established research suppliers that provide verified analytical documentation.

Frequently Asked Questions

What is CJC No DAC + Ipamorelin?
It is a research blend of a short-acting GHRH analog (Mod GRF 1-29 / CJC-1295 without DAC) and the selective GHS-R1a agonist Ipamorelin.

Is this spray approved for human use?
No. Research-grade material is supplied strictly for laboratory and research use only. It is not intended for human or veterinary administration.

Is a Certificate of Analysis provided?
Yes. Reputable research suppliers include batch-specific COAs confirming purity and identity of both peptides.

What is the intended use of research-grade CJC No DAC + Ipamorelin Spray?
Laboratory and research use only. Not for human or veterinary consumption.

Why combine these two peptides?
They activate complementary receptor pathways, producing synergistic growth hormone release in experimental models that is greater than either compound alone.

How should the product be stored?
Follow the specific storage instructions provided by the supplier, typically refrigerated conditions for peptide solutions.

Secure high-purity research material today. Qualified laboratories ready to investigate dual GHRH and ghrelin receptor pathways choose to buy CJC No DAC + Ipamorelin Spray for its verified purity, convenient format, and reliable documentation.